voxilaprevir: Clinical Trials

4 completed. 4 Phase 1.

By phase and status

Phase	Trials	Status
Phase 1	4	Completed 4

Follow voxilaprevir: new trials by email Literature Review of voxilaprevir trials Research Report on voxilaprevir

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Study to Evaluate Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol SOF/VEL/VOX, VOX, Norgestimate/ethinyl estradiol - HCV Infection	Phase 1	Completed	Gilead Sciences	15	2015-10-29	2020-09-02
Pharmacokinetics of Voxilaprevir in Adults With Normal Renal Function and Severe Renal Impairment Voxilaprevir - HCV Infection	Phase 1	Completed	Gilead Sciences	20	2015-05-05	2020-03-20
Pharmacokinetics of Voxilaprevir in Adults With Normal Hepatic Function and Moderate or Severe Hepatic Impairment Voxilaprevir - HCV Infection	Phase 1	Completed	Gilead Sciences	33	2015-03-24	2020-04-09
Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults With Chronic Hepatitis C Virus Infection Voxilaprevir, Placebo to match voxilaprevir, SOF/VEL - Hepatitis C Virus Infection	Phase 1	Completed	Gilead Sciences	101	2014-06-13	2020-09-17

Conditions studied

Hepatitis C (4)  ·  Digestive System Diseases (1)  ·  Enterovirus Infections (1)  ·  Flaviviridae Infections (1)  ·  Hepatitis, Viral, Human (1)  ·  Liver Diseases (1)  ·  Picornaviridae Infections (1)  ·  RNA Virus Infections (1)

Sponsors

Gilead Sciences (4)

Countries

New Zealand (3)  ·  United States (3)  ·  Germany (2)  ·  Puerto Rico (1)

Results publications

PMID 29063860

NIH funding

2015 (2)